Magas vérnyomás: ki dolgozik rajta

Intézményenként egy kártya. Célpontra vagy országra szűkítheted a listát.

• Minden célpont
• AMPK 0
• SGLT2 3
• GLP-1 2
• PPAR 0
• AKT 0
• NLRP3 0
• PI3K 0
• NRF2 1
• HIF-1 0
• STAT3 0
• VEGF 0
• ACE2 0
• SIRT1 0
• TNF 1
• IL-6 1
• mTOR 0
• TLR4 0
• ERK 0
• MAPK 0
• HMGB1 0
• YAP 0
• CXCR4 0
• HSP90 0
• IL-17 1
• AR 1
• PCSK9 3
• APOE 1
• CD19 0
• GPX4 0
• JNK 0
• METTL3 0
• PINK1 0
• PTEN 0
• TP53 0
• ABL1 0
• APOL1 0
• BTK 2
• CD40 0
• FAK 0
• HDAC 0
• IL-1 0
• JAK 0
• MMP-9 0
• PKM2 0
• STK11 0
• CGRP 0
• CTNNB1 0
• DPP-4 0
• FTO 0
• RUNX1 0
• STING 0
• AXL 0
• CD38 0
• COX-2 0
• DMD 0
• GIP 0
• HTT 0
• IDH 0
• IGF1R 0
• MDM2 0

1+ intézményből 1, a friss publikációk és a nyitott vizsgálatok szerint rendezve. Ez nem minőségi rangsor.

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• U.S. Department of Veterans Affairs · IK1

  Evaluating hypertension care delivery in Veterans with rheumatoid arthritis to improve cardiovascular disease prevention

  Durham Va Medical Center· Durham, Egyesült Államok· until 2028. okt.

• U.S. Department of Veterans Affairs · IK6

  ISRM Research Career Scientist Award Application

  Veterans Health Administration· Pittsburgh, Egyesült Államok· until 2031. szept.

• NIH NEI · R01

  Mobile Strategy for Improving Eye Health of Kidney Patients Treated with Dialysis (SIGHT)

  University of Washington· Seattle, Egyesült Államok· 1 383 760 USD awarded in fiscal year 2026· until 2031. aug.

• NIH NIDDK · F31

  Examining Real-World Uptake and Effectiveness of GLP-1 RA in an Urban Population with Type-2 Diabetes

  New York University School of Medicine· New York, Egyesült Államok· 36 947 USD awarded in fiscal year 2026· until 2028. szept.

• NIH NEI · R43

  Novel Ocular Aerosol Drug Delivery Device for the Treatment Optimization of Glaucoma.

  Via Therapeutics, Llc· Austin, Egyesült Államok· 277 143 USD awarded in fiscal year 2026· until 2027. szept.

• European Commission (Horizon Europe) · HORIZON-ERC

  Selective Sensory Vagal Interface: a bionic platform for internal organ modulation (VisceraLink)

  Medizinische Universitaet Wien· Wien, Ausztria· EU contribution 2 210 625 EUR· until 2031. dec.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Design and development of explainable DL/ML model for medical image analysis with high accuracy and reliability (MED-XAI)

  Universidade Nova de Lisboa· Lisboa, Portugália· EU contribution 207 183 EUR· until 2028. dec.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Pulmonary Hypertension in COPD : from Observation to Emerging Novel therapeutic Insights and eXploration (PHOENIX)

  Universitat Zurich· Zurich, Svájc· EU contribution 292 119 EUR· until 2028. dec.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-GF

  Birth and Labor Outcome Optimization through Multimodal AI (BLOOM)

  Universita Degli Studi Gabriele D'annunzio di Chieti-Pescara· Chieti, Olaszország· EU contribution 321 949 EUR· until 2029. máj.· 3 countries

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Unveiling Dynamic Autonomic Regulation in health and disease through Network Physiology (DARNePh)

  Univerzita Komenskeho V Bratislave· Bratislava 1, Szlovákia· EU contribution 172 942 EUR· until 2028. aug.· 2 countries

  The disease is named only in the funder's project summary, not in the title.

10 of 3621 running projects, newest first. Listed amounts together: 2,2 Mrd USD + 231,7 M EUR.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Vizsgálatok, amelyek regiszteradata szerint az egyéni résztvevői adatokat (IPD) megosztják.

• Aerobic Exercise vs Physiological Ischemic Training in Stage 2 Hypertension

  NCT07375407· Universitas Padjadjaran· Forrás

Publikációk erről a betegségről egy MeSH-módszerkifejezés szerint, például szekvenálási vagy képalkotó módszerre.

• Single-Cell Analysis 12
• Organoids 1
• Mendelian Randomization Analysis 85
• CRISPR-Cas Systems 2
• Gene Expression Profiling 52
• Sequence Analysis, RNA 5
• Whole Genome Sequencing 2
• Exome Sequencing 11
• Proteomics 45
• Metabolomics 45
• Mass Spectrometry 3
• Flow Cytometry 4
• Immunohistochemistry 24
• Liquid Biopsy 1
• Xenograft Model Antitumor Assays 1
• Positron-Emission Tomography 6
• Magnetic Resonance Imaging 125
• Machine Learning 101
• Deep Learning 13
• Cohort Studies 416
• Genome-Wide Association Study 82

• Integrative single-cell and bulk transcriptomic analysis identifies monocyte/macrophage senescence-associated candidate genes in pulmonary arterial hypertension.

  Front Immunol, 2026. okt.

• A single-cell census of pulmonary endarterectomies tissue across different anatomical regions in chronic thromboembolic pulmonary hypertension.

  Clin Transl Med, 2026. okt.

• Unveiling the Immune Mechanisms of Hypertension With Single-Cell Transcriptome-Wide Mendelian Randomization.

  FASEB J, 2026. aug.

• Single-cell transcriptomics reveals NDRG1/TGF‑β1 associated vascular smooth muscle cell phenotypic switching in chronic thromboembolic pulmonary hypertension.

  J Thromb Thrombolysis, 2026. máj.

• Integrated Single-Cell Atlas Reveals Cross-Subtype Heterogeneity in Human Pulmonary Hypertension.

  Arterioscler Thromb Vasc Biol, 2026. máj.

• Identification of ATF3 as a Potential Key Biomarker for Hypertensive Nephropathy via Single-Cell Transcriptome Sequencing.

  Inflammation, 2026. máj.

• Identification of key driver genes in idiopathic pulmonary arterial hypertension by single-cell RNA sequencing and experimental validation.

  Biochem Biophys Res Commun, 2026. ápr.

• Integrative single-cell RNA-seq and ATAC-seq analysis reveals the key role of inflammatory cell activation in pulmonary arterial hypertension.

  Front Immunol, 2026. ápr.

• Bulk and single-cell transcriptomics for identification of potential diagnostic biomarkers associated with pulmonary arterial hypertension and integrated stress response and experimental validation.

  Clin Exp Hypertens, 2026. febr.

• Comprehensive profiling of lactylation-associated genes in pulmonary hypertension through bulk and single-cell RNA sequencing integration.

  Respir Res, 2026. jan.

Megmutatjuk, a betegség mely célpontjait említi az absztrakt, és onnan a rajtuk dolgozókhoz jutsz.